Verano Holdings (VRNO) Change in Account Payables (2021 - 2026)
Verano Holdings (VRNO) reported Change in Account Payables of -$5.7 million for Q1 2026, down 175.52% year-over-year from $7.6 million in Q1 2025, and down 329.87% quarter-over-quarter from -$1.3 million in Q4 2025.
Verano Holdings (VRNO) Change in Account Payables (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Change in Account Payables data on file, last reported at -$5.7 million in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$5.7 million, down 175.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.9 million (down 206.61% YoY), and the FY2025 annual result was $5.4 million, up 228.5% from the prior year.
- Change in Account Payables declined to -$5.7 million in Q1 2026 per VRNO's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $19.9 million in Q1 2022 and troughed at -$13.7 million in Q4 2022.
- A 5-year average of -$1.2 million and a median of -$3.0 million in 2024 frame the typical range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 2522.59% in 2024 and fell as far as 495.85% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$13.7 million in 2022, then soared by 96.32% to -$506000.0 in 2023, then slumped by 495.85% to -$3.0 million in 2024, then surged by 55.92% to -$1.3 million in 2025, then sank by 329.87% to -$5.7 million in 2026.
- Business Quant data shows VRNO's Change in Account Payables at -$5.7 million in Q1 2026, -$1.3 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 167.64 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 190,000.00 |
| 10 | Verano Holdings | - | - | 98.98 Mn | -5.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.71 Mn |
| Mar 31, 2026 | -5.71 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Dec 31, 2025 | -1.33 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | -6.21 Mn |
| Jun 30, 2025 | -6.21 Mn |
| Mar 31, 2025 | 7.57 Mn |
| Mar 31, 2025 | 7.57 Mn |
| Dec 31, 2024 | -3.02 Mn |
| Dec 31, 2024 | -3.02 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Sep 30, 2024 | 8.71 Mn |
| Jun 30, 2024 | -5.84 Mn |
| Jun 30, 2024 | -5.84 Mn |
| Mar 31, 2024 | -4.03 Mn |
| Mar 31, 2024 | -4.03 Mn |
| Dec 31, 2023 | -506,000.00 |
| Dec 31, 2023 | -506,000.00 |